MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region

Antiviral Research

Volumn 93, Issue 2, 2012, Pages 270-279

  Wang, Linlin ^a   Qin, Ying ^a   Tong, Lei ^a   Wu, Shuo ^a   Wang, Qiang ^a   Jiao, Qingguo ^a   Guo, Zhiwei ^a   Lin, Lexun ^a   Wang, Ruixue ^a   Zhao, Wenran ^a   Zhong, Zhaohua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

2C coding region; Antiviral activity; Biosynthesis; Coxsackievirus B3; MiR 342 5p

Indexed keywords

ANTIINFECTIVE AGENT; EPIDERMAL GROWTH FACTOR; FIREFLY LUCIFERASE; GREEN FLUORESCENT PROTEIN; MICRORNA; OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; COXSACKIE VIRUS B3; GENE EXPRESSION; GENE SEQUENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA SYNTHESIS; VIRUS GENOME; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; COXSACKIEVIRUS INFECTIONS; DOWN-REGULATION; ENTEROVIRUS B, HUMAN; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICRORNAS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PROTEIN BIOSYNTHESIS; VIRAL NONSTRUCTURAL PROTEINS;

COXSACKIEVIRUS; HUMAN ENTEROVIRUS B; MUS; RENILLA LUCIFERASE;

EID: 84862778050     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.12.004     Document Type: Article

References (54)

1. Alves L., Niemeier S., Hauenschild A., Rehmsmeier M., Merkle T. Comprehensive prediction of novel microRNA targets in Arabidopsis thaliana. Nucleic Acids Res. 2009, 37:4010-4021.
2. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
3. Asli N.S., Pitulescu M.E., Kessel M. MicroRNAs in organogenesis and disease. Curr. Mol. Med. 2008, 8:698-710.
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Bedard K.M., Semler B.L. Regulation of picornavirus gene expression. Microbes Infect. 2004, 6:702-713.
6. Bowles N.E., Richardson P.J., Olsen E.G., Archard L.C. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986, 1:1120-1123.
7. Cittelly D.M., Das P.M., Spoelstra N.S., Edgerton S.M., Richer J.K., Thor A.D., Jones F.E. Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol. Cancer 2010, 9:317.
8. Cui A., Yu D., Zhu Z., Meng L., Li H., Liu J., Liu G., Mao N., Xu W. An outbreak of aseptic meningitis caused by coxsackievirus A9 in Gansu, the People's Republic of China. Virol. J. 2010, 7:72.
9. Cui L., Guo X., Qi Y., Qi X., Ge Y., Shi Z., Wu T., Shan J., Shan Y., Zhu Z., Wang H. Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J. Biomed. Biotechnol. 2010, 2010:425939.
10. Esfandiarei M., McManus B.M. Molecular biology and pathogenesis of viral myocarditis. Annu. Rev. Pathol. 2008, 3:127-155.
11. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
12. Feuer R., Mena I., Pagarigan R., Slifka M.K., Whitton J.L. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 2002, 76:4430-4440.
13. Ghosh Z., Mallick B., Chakrabarti J. Cellular versus viral microRNAs in host-virus interaction. Nucleic Acids Res. 2009, 37:1035-1048.
14. Grassmann R., Jeang K.T. The roles of microRNAs in mammalian virus infection. Biochim. Biophys. Acta 2008, 1779:706-711.
15. Ho B.C., Yu S.L., Chen J.J., Chang S.Y., Yan B.S., Hong Q.S., Singh S., Kao C.L., Chen H.Y., Su K.Y., Li K.C., Cheng C.L., Cheng H.W., Lee J.Y., Lee C.N., Yang P.C. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe 2011, 9:58-69.
16. Houzet L., Yeung M.L., de Lame V., Desai D., Smith S.M., Jeang K.T. MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 2008, 5:118.
17. Huang J., Wang F., Argyris E., Chen K., Liang Z., Tian H., Huang W., Squires K., Verlinghieri G., Zhang H. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 2007, 13:1241-1247.
18. Jiang J., Gusev Y., Aderca I., Mettler T.A., Nagorney D.M., Brackett D.J., Roberts L.R., Schmittgen T.D. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res. 2008, 14:419-427.
19. Jin O., Sole M.J., Butany J.W., Chia W.K., McLaughlin P.R., Liu P., Liew C.C. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990, 82:8-16.
20. Jopling C.L., Yi M.K., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577.
21. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999, 99:1091.
22. Kelly E.J., Hadac E.M., Cullen B.R., Russell S.J. MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interference. PLoS Pathog. 2010, 6:e1000820.
23. Kloosterman W.P., Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11:441-450.
24. Knowlton K.U. CVB infection and mechanisms of viral cardiomyopathy. Curr. Top. Microbiol. Immunol. 2008, 323:315-335.
25. Kurzynska-Kokorniak A., Jackowiak P., Figlerowicz M. Human- and virus-encoded microRNAs as potential targets of antiviral therapy. Mini Rev. Med. Chem. 2009, 9:927-937.
26. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foa R., Schliwka J., Fuchs U., Novosel A., Muller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
27. Lecellier C.H., Dunoyer P., Arar K., Lehmann-Che J., Eyquem S., Himber C., Saïb A., Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science 2005, 308:557.
28. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
29. Li L.M., Hu Z.B., Zhou Z.X., Chen X., Liu F.Y., Zhang J.F., Shen H.B., Zhang C.Y., Zen K. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res. 2010, 70:9798-9807.
30. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
31. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
32. Ma L., Liu J., Shen J., Liu L., Wu J., Li W., Luo J., Chen Q., Qian C. Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol. Ther. 2010, 9:554-561.
33. Martin A.B., Webber S., Fricker F.J., Jaffe R., Demmler G., Kearney D., Zhang Y.H., Bodurtha J., Gelb B., Ni J. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 1994, 90:330-339.
34. Nunnari G., Schnell M.J. MicroRNA-122: a therapeutic target for hepatitis C virus (HCV) infection. Front. Biosci. (Schol. Ed.) 2011, 3:1032-1037.
35. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919.
36. Rajewsky N. MicroRNA target predictions in animals. Nat. Genet. 2006, 38(Suppl.):S8-S13.
37. Sakurai F., Katayama K., Mizuguchi H. MicroRNA-regulated transgene expression systems for gene therapy and virotherapy. Front. Biosci. 2011, 17:2389-2401.
38. Sall A., Liu Z., Zhang H.M., Yuan J., Lim T., Su Y., Yang D. MicroRNAs-based therapeutic strategy for virally induced diseases. Curr. Drug Discov. Technol. 2008, 5:49-58.
39. Schmittgen T.D., Jiang J., Liu Q., Yang L. A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res. 2004, 32:e43.
40. Song L., Liu H., Gao S., Jiang W., Huang W. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J. Virol. 2010, 84:8849-8860.
41. Sullivan C.S., Ganem D. MicroRNAs and viral infection. Mol. Cell 2005, 20:3-7.
42. Tang X., Gal J., Zhuang X., Wang W., Zhu H., Tang G. A simple array platform for microRNA analysis and its application in mouse tissues. RNA 2007, 13:1803-1822.
43. Tong L., Lin L., Zhao W., Wang B., Wu S., Liu H., Zhong X., Cui Y., Gu H., Zhang F., Zhong Z. Destabilization of coxsackievirus B3 genome integrated with enhanced green fluorescent protein gene. Intervirology 2011, 54:268-275.
44. Tracy S., Chapman N.M., McManus B.M., Pallansch M.A., Beck M.A., Carstens J. A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J. Mol. Cell. Cardiol. 1990, 22:403-414.
45. Vargova A., Bopegamage S., Borsanyiova M., Petrovicova A., Benkovicova M. Coxsackievirus infection of mice. II. Viral kinetics and histopathological changes in mice experimentally infected with coxsackievirus B3 by intraperitoneal route. Acta Virol. 2003, 47:253-257.
46. Vasilescu C., Rossi S., Shimizu M., Tudor S., Veronese A., Ferracin M., Nicoloso M.S., Barbarotto E., Popa M., Stanciulea O., Fernandez M.H., Tulbure D., Bueso-Ramos C.E., Negrini M., Calin G.A. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS ONE 2009, 4:e7405.
47. Verma N.A., Zheng X.T., Harris M.U., Cadichon S.B., Melin-Aldana H., Khetsuriani N., Oberste M.S., Shulman S.T. Outbreak of life-threatening coxsackievirus B1 myocarditis in neonates. Clin. Infect. Dis. 2009, 49:759-763.
48. Wald A.I., Hoskins E.E., Wells S.I., Ferris R.L., Khan S.A. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 2011, 33:504-512.
49. Wang H., Wu J., Meng X., Ying X., Zuo Y., Liu R., Pan Z., Kang T., Huang W. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 2011, 32:1033-1042.
50. Weiler J., Hunziker J., Hall J. Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?. Gene Ther. 2006, 13:496-502.
51. Wong A.H., Lau C.S., Cheng P.K., Ng A.Y., Lim W.W. Coxsackievirus B3-associated aseptic meningitis: an emerging infection in Hong Kong. J. Med. Virol. 2011, 83:483-489.
52. Wu X., Wu S., Tong L., Luan T., Lin L., Lu S., Zhao W., Ma Q., Liu H., Zhong Z. MiR-122 affects the viability and apoptosis of hepatocellular carcinoma cells. Scand. J. Gastroenterol. 2009, 44:1332-1339.
53. Yuan J., Cheung P.K., Zhang H., Chau D., Yanagawa B., Cheung C., Luo H., Wang Y., Suarez A., McManus B.M., Yang D. A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts. Lab. Invest. 2004, 84:703-714.
54. Zhong Z., Li X., Zhao W., Tong L., Liu J., Wu S., Lin L., Zhang Z., Tian Y., Zhang F. Mutations at nucleotides 573 and 579 within 5'-untranslated region augment the virulence of coxsackievirus B1. Virus Res. 2008, 135:255-259.